2025
SJR Q1
JCR Q2 · 3,7
17 matched articles
SCIE
Journal detail
Neuromodulation
- Publisher
- International Neuromodulation Society
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
1094715915251403
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 1,076
- Quartile Q1
- H-Index 86
- Cites/doc 3,31
- Docs (3y) 532
- Cites (3y) 1.961
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 3,7
- 5Y JIF 3,6
- JCI 1,03
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Anesthesiology and Pain Medicine Q1
- Medicine (miscellaneous) Q1
- Neurology Q1
- Neurology (clinical) Q1
Areas
- Medicine
- Neuroscience
WoS categories
- Medicine, Research & Experimental | Clinical Neurology | Neurosciences
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q2 | 1,076 | 3,7 | 3,6 | 1,03 | Q1 | 86 |
| 2024 | Q1 | Q2 | 1,076 | 3,5 | 3,5 | 0,99 | Q2 | 82 |
| 2023 | Q1 | Q2 | 0,919 | 3,2 | 3,5 | 0,75 | Q2 | 82 |
| 2022 | Q1 | Q3 | 0,827 | 2,8 | 3,3 | 0,73 | Q2 | 82 |
| 2021 | Q1 | Q3 | 0,787 | 3 | 3,7 | 0,84 | Q2 | 82 |
| 2020 | Q1 | Q2 | 1,296 | 4,7 | 4,7 | 1,16 | Q1 | 82 |
| 2019 | Q1 | Q1 | 1,255 | 4 | 3,7 | 1,13 | Q1 | 82 |
| 2018 | — | Q2 | — | 2,7 | 2,8 | 0,93 | Q2 | — |
| 2017 | Q1 | Q2 | 1,34 | 2,8 | 3 | 0,99 | Q2 | 82 |
| 2016 | Q1 | Q2 | 1,087 | 2,6 | 2,5 | — | — | 82 |
| 2015 | Q1 | Q2 | 1,081 | 2,4 | 2,1 | — | — | 82 |
| 2014 | Q1 | Q2 | 0,8 | 2,7 | 2,3 | — | — | 82 |
| 2013 | Q2 | Q3 | 0,512 | 1,8 | 1,5 | — | — | 82 |
| 2012 | Q2 | Q3 | 0,298 | 1,2 | 1,4 | — | — | 82 |
| 2011 | Q1 | Q3 | 0,606 | 1,2 | 1,3 | — | — | 82 |
| 2010 | Q2 | Q4 | 0,451 | 1,1 | 1,1 | — | — | 82 |
| 2009 | — | Q4 | — | 1 | 1,2 | — | — | — |
| 2008 | — | Q4 | — | 1 | 1,3 | — | — | — |
| 2007 | — | Q3 | — | 1,4 | 1,4 | — | — | — |
| 2006 | — | Q4 | — | 0,7 | — | — | — | — |
| 2005 | — | Q4 | — | 0,5 | — | — | — | — |
| 2004 | — | Q4 | — | 0,8 | — | — | — | — |
| 2003 | — | Q3 | — | 0,9 | — | — | — | — |
| 2002 | — | Q3 | — | 0,9 | — | — | — | — |
| 2001 | — | Q3 | — | 1,1 | — | — | — | — |
| 2000 | — | Q2 | — | 1,2 | — | — | — | — |
| 1999 | — | Q2 | — | 2,1 | — | — | — | — |
| 1998 | — | Q4 | — | — | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | CLINICAL NEUROLOGY | SCIE | Q2 | Q1 | 85/296 |
| 2025 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q1 | 75/191 |
| 2025 | NEUROSCIENCES | SCIE | Q2 | Q2 | 126/330 |
| 2024 | CLINICAL NEUROLOGY | SCIE | Q2 | Q2 | 74/286 |
| 2024 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q2 | 68/195 |
| 2024 | NEUROSCIENCES | SCIE | Q2 | Q2 | 109/314 |
| 2023 | CLINICAL NEUROLOGY | SCIE | Q2 | Q2 | 82/280 |
| 2023 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q2 | 81/189 |
| 2022 | CLINICAL NEUROLOGY | SCIE | Q3 | Q2 | 121/212 |
| 2022 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q2 | 91/136 |
| 2021 | CLINICAL NEUROLOGY | SCIE | Q3 | Q2 | 131/212 |
| 2021 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q2 | 96/139 |
| 2020 | CLINICAL NEUROLOGY | SCIE | Q2 | Q1 | 54/208 |
| 2020 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q1 | 54/140 |
| 2019 | CLINICAL NEUROLOGY | SCIE | Q1 | Q1 | 46/204 |
| 2019 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q1 | 52/139 |
| 2018 | CLINICAL NEUROLOGY | SCIE | Q2 | Q2 | 98/199 |
| 2018 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q2 | 71/136 |
| 2017 | CLINICAL NEUROLOGY | SCIE | Q2 | Q2 | 92/197 |
| 2017 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q2 | 66/133 |
| 2016 | CLINICAL NEUROLOGY | SCIE | Q2 | — | 86/194 |
| 2016 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 61/128 |
| 2015 | CLINICAL NEUROLOGY | SCIE | Q2 | — | 93/193 |
| 2015 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 61/124 |
| 2014 | CLINICAL NEUROLOGY | SCIE | Q2 | — | 76/192 |
| 2014 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 54/123 |
| 2013 | CLINICAL NEUROLOGY | SCIE | Q3 | — | 122/194 |
| 2013 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 78/124 |
| 2012 | CLINICAL NEUROLOGY | SCIE | Q4 | — | 152/193 |
| 2012 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 88/121 |
| 2011 | CLINICAL NEUROLOGY | SCIE | Q4 | — | 151/192 |
| 2011 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 80/112 |
| 2010 | CLINICAL NEUROLOGY | SCIE | Q4 | — | 148/185 |
| 2010 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 82/106 |
| 2009 | CLINICAL NEUROLOGY | SCIE | Q4 | — | 136/167 |
| 2009 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 77/93 |
| 2008 | CLINICAL NEUROLOGY | SCIE | Q4 | — | 129/156 |
| 2008 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 69/83 |
| 2007 | CLINICAL NEUROLOGY | SCIE | Q3 | — | 98/146 |
| 2007 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 56/81 |
| 2006 | CLINICAL NEUROLOGY | SCIE | Q4 | — | 126/147 |
| 2006 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 65/76 |
| 2005 | CLINICAL NEUROLOGY | SCIE | Q4 | — | 130/148 |
| 2005 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 65/72 |
| 2004 | CLINICAL NEUROLOGY | SCIE | Q4 | — | 116/140 |
| 2004 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 58/71 |
| 2003 | CLINICAL NEUROLOGY | SCIE | Q3 | — | 101/135 |
| 2003 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 52/72 |
| 2002 | CLINICAL NEUROLOGY | SCIE | Q3 | — | 92/138 |
| 2002 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 55/74 |
| 2001 | CLINICAL NEUROLOGY | SCIE | Q3 | — | 72/136 |
| 2001 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 47/75 |
| 2000 | CLINICAL NEUROLOGY | SCIE | Q2 | — | 64/137 |
| 2000 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 42/74 |
| 1999 | CLINICAL NEUROLOGY | SCIE | Q2 | — | 40/132 |
| 1999 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 23/76 |
| 1998 | CLINICAL NEUROLOGY | SCIE | Q4 | — | 124/125 |
| 1998 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 70/72 |